Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2001 Aug;85(4):618–624. doi: 10.1054/bjoc.2001.1980

Differences between human breast cell lines in susceptibility towards growth inhibition by genistein

K Dampier 1, E A Hudson 1, L M Howells 1, M M Manson 1, R A Walker 2, A Gescher 1
PMCID: PMC2364092  PMID: 11506505

Abstract

Genistein is thought to contribute to the putative breast cancer preventive activity of soya. The mechanisms by which it arrests the growth of breast cells are incompletely understood. In order to explore generic features of the modulation of human breast cell growth by genistein, its effects on cell lines MCF-7, ZR-75.1, T47-D, MDA-MB 468, MDA-MB 231 and HBL 100 were compared. Genistein at 1 μM stimulated growth only in MCF-7 cells. At 10 μM it arrested the growth of all 6 cell types, however that of T47-D and HBL 100 cells only in medium with reduced (2%) fetal calf serum. Genistein induced apoptosis in only MDA-MB 468 cells. It arrested cells in the G2 stage of the cell cycle in all cell lines except ZR-75.1. Cells differed in their susceptibility towards inhibition by genistein of phorbol ester-induced proto-oncogene c-fos levels, transcription factor activator protein-1 (AP-1) activity and extracellular signal-regulated kinase (ERK) activity. Genistein augmented anisomycin-induced levels of proto-oncogene c-jun in ZR 75.1 and MCF-7 cells. The results suggest that induction of apoptosis, G2 cell cycle arrest and inhibition of c-fos expression, AP-1 transactivation and ERK phosphorylation may contribute to the growth-inhibitory effect of genistein in some breast cell types, but none of these effects of genistein constitutes a generic mode of growth-arresting action. © 2001 Cancer Research Campaign http://www.bjcancer.com

Keywords: breast cancer, cancer chemoprevention, genistein, soya, malignant cell growth, signal transduction

Full Text

The Full Text of this article is available as a PDF (86.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adlercreutz C. H., Goldin B. R., Gorbach S. L., Höckerstedt K. A., Watanabe S., Hämäläinen E. K., Markkanen M. H., Mäkelä T. H., Wähälä K. T., Adlercreutz T. Soybean phytoestrogen intake and cancer risk. J Nutr. 1995 Mar;125(3 Suppl):757S–770S. doi: 10.1093/jn/125.3_Suppl.757S. [DOI] [PubMed] [Google Scholar]
  2. Akiyama T., Ishida J., Nakagawa S., Ogawara H., Watanabe S., Itoh N., Shibuya M., Fukami Y. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem. 1987 Apr 25;262(12):5592–5595. [PubMed] [Google Scholar]
  3. Angel P., Karin M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta. 1991 Dec 10;1072(2-3):129–157. doi: 10.1016/0304-419x(91)90011-9. [DOI] [PubMed] [Google Scholar]
  4. Balabhadrapathruni S., Thomas T. J., Yurkow E. J., Amenta P. S., Thomas T. Effects of genistein and structurally related phytoestrogens on cell cycle kinetics and apoptosis in MDA-MB-468 human breast cancer cells. Oncol Rep. 2000 Jan-Feb;7(1):3–12. [PubMed] [Google Scholar]
  5. Barnes S., Peterson T. G. Biochemical targets of the isoflavone genistein in tumor cell lines. Proc Soc Exp Biol Med. 1995 Jan;208(1):103–108. doi: 10.3181/00379727-208-43840. [DOI] [PubMed] [Google Scholar]
  6. Choi Y. H., Zhang L., Lee W. H., Park K. Y. Genistein-induced G2/M arrest is associated with the inhibition of cyclin B1 and the induction of p21 in human breast carcinoma cells. Int J Oncol. 1998 Aug;13(2):391–396. doi: 10.3892/ijo.13.2.391. [DOI] [PubMed] [Google Scholar]
  7. Croisy-Delcey M., Croisy A., Mousset S., Letourneur M., Bisagni E., Jacquemin-Sablon A., Pierre J. Genistein analogues: effects on epidermal growth factor receptor tyrosine kinase and on stress-activated pathways. Biomed Pharmacother. 1997;51(6-7):286–294. doi: 10.1016/S0753-3322(97)83545-7. [DOI] [PubMed] [Google Scholar]
  8. Dotzlaw H., Leygue E., Watson P. H., Murphy L. C. Expression of estrogen receptor-beta in human breast tumors. J Clin Endocrinol Metab. 1997 Jul;82(7):2371–2374. doi: 10.1210/jcem.82.7.4212. [DOI] [PubMed] [Google Scholar]
  9. Enmark E., Pelto-Huikko M., Grandien K., Lagercrantz S., Lagercrantz J., Fried G., Nordenskjöld M., Gustafsson J. A. Human estrogen receptor beta-gene structure, chromosomal localization, and expression pattern. J Clin Endocrinol Metab. 1997 Dec;82(12):4258–4265. doi: 10.1210/jcem.82.12.4470. [DOI] [PubMed] [Google Scholar]
  10. Fioravanti L., Cappelletti V., Miodini P., Ronchi E., Brivio M., Di Fronzo G. Genistein in the control of breast cancer cell growth: insights into the mechanism of action in vitro. Cancer Lett. 1998 Aug 14;130(1-2):143–152. doi: 10.1016/s0304-3835(98)00130-x. [DOI] [PubMed] [Google Scholar]
  11. Fotsis T., Pepper M., Adlercreutz H., Fleischmann G., Hase T., Montesano R., Schweigerer L. Genistein, a dietary-derived inhibitor of in vitro angiogenesis. Proc Natl Acad Sci U S A. 1993 Apr 1;90(7):2690–2694. doi: 10.1073/pnas.90.7.2690. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Germain M., Affar E. B., D'Amours D., Dixit V. M., Salvesen G. S., Poirier G. G. Cleavage of automodified poly(ADP-ribose) polymerase during apoptosis. Evidence for involvement of caspase-7. J Biol Chem. 1999 Oct 1;274(40):28379–28384. doi: 10.1074/jbc.274.40.28379. [DOI] [PubMed] [Google Scholar]
  13. Hsieh C. Y., Santell R. C., Haslam S. Z., Helferich W. G. Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo. Cancer Res. 1998 Sep 1;58(17):3833–3838. [PubMed] [Google Scholar]
  14. Karin M. The regulation of AP-1 activity by mitogen-activated protein kinases. Philos Trans R Soc Lond B Biol Sci. 1996 Feb 29;351(1336):127–134. doi: 10.1098/rstb.1996.0008. [DOI] [PubMed] [Google Scholar]
  15. Kaufmann W. K. Human topoisomerase II function, tyrosine phosphorylation and cell cycle checkpoints. Proc Soc Exp Biol Med. 1998 Mar;217(3):327–334. doi: 10.3181/00379727-217-44240. [DOI] [PubMed] [Google Scholar]
  16. Kuiper G. G., Carlsson B., Grandien K., Enmark E., Häggblad J., Nilsson S., Gustafsson J. A. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology. 1997 Mar;138(3):863–870. doi: 10.1210/endo.138.3.4979. [DOI] [PubMed] [Google Scholar]
  17. Kuiper G. G., Lemmen J. G., Carlsson B., Corton J. C., Safe S. H., van der Saag P. T., van der Burg B., Gustafsson J. A. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology. 1998 Oct;139(10):4252–4263. doi: 10.1210/endo.139.10.6216. [DOI] [PubMed] [Google Scholar]
  18. Lamartiniere C. A., Moore J., Holland M., Barnes S. Neonatal genistein chemoprevents mammary cancer. Proc Soc Exp Biol Med. 1995 Jan;208(1):120–123. doi: 10.3181/00379727-208-43843. [DOI] [PubMed] [Google Scholar]
  19. Le Bail J. C., Varnat F., Nicolas J. C., Habrioux G. Estrogenic and antiproliferative activities on MCF-7 human breast cancer cells by flavonoids. Cancer Lett. 1998 Aug 14;130(1-2):209–216. doi: 10.1016/s0304-3835(98)00141-4. [DOI] [PubMed] [Google Scholar]
  20. Leppä S., Bohmann D. Diverse functions of JNK signaling and c-Jun in stress response and apoptosis. Oncogene. 1999 Nov 1;18(45):6158–6162. doi: 10.1038/sj.onc.1203173. [DOI] [PubMed] [Google Scholar]
  21. Li Y., Upadhyay S., Bhuiyan M., Sarkar F. H. Induction of apoptosis in breast cancer cells MDA-MB-231 by genistein. Oncogene. 1999 May 20;18(20):3166–3172. doi: 10.1038/sj.onc.1202650. [DOI] [PubMed] [Google Scholar]
  22. MacFarlane M., Cain K., Sun X. M., Alnemri E. S., Cohen G. M. Processing/activation of at least four interleukin-1beta converting enzyme-like proteases occurs during the execution phase of apoptosis in human monocytic tumor cells. J Cell Biol. 1997 Apr 21;137(2):469–479. doi: 10.1083/jcb.137.2.469. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Messina M. J., Persky V., Setchell K. D., Barnes S. Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutr Cancer. 1994;21(2):113–131. doi: 10.1080/01635589409514310. [DOI] [PubMed] [Google Scholar]
  24. Nakatani K., Thompson D. A., Barthel A., Sakaue H., Liu W., Weigel R. J., Roth R. A. Up-regulation of Akt3 in estrogen receptor-deficient breast cancers and androgen-independent prostate cancer lines. J Biol Chem. 1999 Jul 30;274(31):21528–21532. doi: 10.1074/jbc.274.31.21528. [DOI] [PubMed] [Google Scholar]
  25. Peterson G. Evaluation of the biochemical targets of genistein in tumor cells. J Nutr. 1995 Mar;125(3 Suppl):784S–789S. doi: 10.1093/jn/125.suppl_3.784S. [DOI] [PubMed] [Google Scholar]
  26. Schultze-Mosgau M. H., Dale I. L., Gant T. W., Chipman J. K., Kerr D. J., Gescher A. Regulation of c-fos transcription by chemopreventive isoflavonoids and lignans in MDA-MB-468 breast cancer cells. Eur J Cancer. 1998 Aug;34(9):1425–1431. doi: 10.1016/s0959-8049(98)00223-8. [DOI] [PubMed] [Google Scholar]
  27. Shao Z. M., Alpaugh M. L., Fontana J. A., Barsky S. H. Genistein inhibits proliferation similarly in estrogen receptor-positive and negative human breast carcinoma cell lines characterized by P21WAF1/CIP1 induction, G2/M arrest, and apoptosis. J Cell Biochem. 1998 Apr 1;69(1):44–54. [PubMed] [Google Scholar]
  28. Smith L. M., Birrer M. J., Stampfer M. R., Brown P. H. Breast cancer cells have lower activating protein 1 transcription factor activity than normal mammary epithelial cells. Cancer Res. 1997 Jul 15;57(14):3046–3054. [PubMed] [Google Scholar]
  29. Wang Y., Zhang X., Lebwohl M., DeLeo V., Wei H. Inhibition of ultraviolet B (UVB)-induced c-fos and c-jun expression in vivo by a tyrosine kinase inhibitor genistein. Carcinogenesis. 1998 Apr;19(4):649–654. doi: 10.1093/carcin/19.4.649. [DOI] [PubMed] [Google Scholar]
  30. Zava D. T., Duwe G. Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro. Nutr Cancer. 1997;27(1):31–40. doi: 10.1080/01635589709514498. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES